GeneDx Holdings (WGSWW) EBT Margin Growth (1y) (2021 - 2026)
GeneDx Holdings (WGSWW) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -2,855.00 |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 13.00 |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 109.00 |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 10.00 |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 665.00 |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 113.00 |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -53.00 |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -309.00 |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -71.00 |
| 10 | GeneDx Holdings | - | - | 68.21 Mn | -5,406.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,406.00 |
| Dec 31, 2025 | -2,073.00 |
| Sep 30, 2025 | 455.00 |
| Jun 30, 2025 | 5,193.00 |
| Mar 31, 2025 | 2,557.00 |
| Dec 31, 2024 | 5,126.00 |
| Sep 30, 2024 | 6,878.00 |
| Jun 30, 2024 | 5,468.00 |
| Mar 31, 2024 | 10,916.00 |
| Dec 31, 2023 | 45,753.00 |
| Sep 30, 2023 | 1,363.00 |
| Jun 30, 2023 | 27,642.00 |
| Mar 31, 2023 | 84.00 |
| Dec 31, 2022 | -43,361.00 |
| Sep 30, 2022 | -16,909.00 |
| Jun 30, 2022 | -27,456.00 |
| Mar 31, 2022 | 15,615.00 |
| Dec 31, 2021 | -713.00 |
| Sep 30, 2021 | 22,245.00 |
| Jun 30, 2021 | 1,530.00 |